Detalhe da pesquisa
1.
The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming.
Nat Immunol
; 20(7): 879-889, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182807
2.
PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program.
Mod Pathol
; 32(6): 741-754, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666052
3.
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.
Am J Pathol
; 187(8): 1700-1716, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28627414
4.
Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Blood
; 128(26): 3083-3100, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27760757
5.
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53.
Mod Pathol
; 30(6): 854-876, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281555
6.
Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Mod Pathol
; 28(12): 1555-73, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541272
7.
Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
Mod Pathol
; 28(10): 1297-314, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26248897
8.
Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.
Mod Pathol
; 28(9): 1202-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26111978
9.
MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Blood
; 122(15): 2630-40, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23982177
10.
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study.
Blood
; 121(14): 2715-24, 2013 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23343832
11.
Temporal transcriptional response during infection of type II alveolar epithelial cells with Francisella tularensis live vaccine strain (LVS) supports a general host suppression and bacterial uptake by macropinocytosis.
J Biol Chem
; 288(15): 10780-91, 2013 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322778
12.
Reverse-phase protein array for prediction of patients at low risk of developing bone metastasis from breast cancer.
Oncologist
; 19(9): 909-14, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25117064
13.
FuncPEP v2.0: An Updated Database of Functional Short Peptides Translated from Non-Coding RNAs.
Noncoding RNA
; 10(2)2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668378
14.
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.
Clin Cancer Res
; 30(8): 1655-1668, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277235
15.
SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor-Induced Growth Suppression.
Clin Cancer Res
; 29(21): 4464-4478, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37581614
16.
Pirtobrutinib inhibits wild-type and mutant Bruton's tyrosine kinase-mediated signaling in chronic lymphocytic leukemia.
Blood Cancer J
; 12(5): 80, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595730
17.
Lentiviral interferon: A novel method for gene therapy in bladder cancer.
Mol Ther Oncolytics
; 26: 141-157, 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847448
18.
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer.
Sci Adv
; 8(50): eabn7983, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525493
19.
ATR Inhibition Induces CDK1-SPOP Signaling and Enhances Anti-PD-L1 Cytotoxicity in Prostate Cancer.
Clin Cancer Res
; 27(17): 4898-4909, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168048
20.
PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer.
Mol Cancer Ther
; 20(9): 1680-1691, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158347